-
Budget Impact of an Ambulatory Minimally Invasive Surgical Treatment in an Italian Public Hospital
Sep 9, 2025, 16:22 PM -
Cardiovascular Event Rates and Mortality Among Secondary-Prevention Hypercholesterolemia Patients in Japan
Sep 9, 2025, 16:22 PM -
Improving the Transferability of Global RCT Data to Inform Cost-Effectiveness Models in Japan: A Structured Framework for C2H Submissions
Sep 9, 2025, 16:22 PM -
Accelerating HEOR Using Petri Net-Based Simulation Informed by Real-World Data
Sep 9, 2025, 16:22 PM -
Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model
Sep 9, 2025, 16:22 PM -
Assessment of Severity Modifiers vs. End-of-Life Criteria in Oncology
Sep 9, 2025, 16:22 PM -
The Changing Prevalence of Multicomorbid Patients in the US
Sep 9, 2025, 16:22 PM -
Use of AI in Breast Cancer Screening in England Has a Minimal Impact on Greenhouse Gas Emissions and May Increase Diagnostic Accuracy
Sep 9, 2025, 16:22 PM -
Weighting the OrPhar-SEFH MCDA Framework for Its Use in Ultrarare Kidney Diseases
Sep 9, 2025, 16:22 PM -
Danicopan: A Dominant Option for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Residual Hemolytic Anemia in Spain
Sep 9, 2025, 16:22 PM -
Exploratory Assessment of the Societal Impact of Changing Informal Care Hours in the Netherlands
Sep 9, 2025, 16:22 PM -
Modeling the Public Health Impact of Nirsevimab and Maternal Vaccination With RSVpreF Against Infant Respiratory Syncytial Virus Infection in Germany
Sep 9, 2025, 16:22 PM -
The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access
Sep 9, 2025, 16:22 PM -
Economic Value of Dupilumab in Preventing and Treating Comorbid Asthma in Pediatric Patients With Atopic Dermatitis: A Cost-Offset Model From the Italian Payer Perspective
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Immune Checkpoint Inhibitors Chemotherapy (ICI+CT) vs. ICI Monotherapy (ICI) in Untreated Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
AI for Pricing Reimbursement: When to Green-Light, When to Red-Light?
Sep 9, 2025, 16:22 PM -
Timing Matters: Missed Opportunity to Prevent RSV Cases in Older Adults in Germany: A Markov Model Analysis
Sep 9, 2025, 16:22 PM -
Comparison EQ-5D-Y-3L Responses Between Child Self-Reports and Caregiver Proxy Reports
Sep 9, 2025, 16:22 PM -
The Use of Multiple Sleep Medications Is Highly Prevalent
Sep 9, 2025, 16:22 PM -
Addressing Bias in Indirect Treatment Comparisons: A Framework for Identifying TEMs and PVs
Sep 9, 2025, 16:22 PM
